Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2020 Filed Dec 15, 2020 21:37 UTC |
Maier Dennis BVice President, Operations
|
SaleCommon Stock | 1,843 | $21.85 | $40,269.73 |
DisclosureSEC source: 0000784199-20-000216 · certent-form4.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,240 F1 · price: Reflects weighted average price. Range of prices were between $21.72 to $21.98. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 13:39 UTC |
Horton AmyVP, Chief Accounting Officer
|
GiftCommon Stock | 1,375 | $21.25 | $29,218.75 |
DisclosureSEC source: 0000784199-20-000220 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,267 F2 · shares: 1,375 shares were gifted by the reporting person to a charity. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 13:39 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionCommon stock | 6,666 | $9.97 | $66,460.02 |
DisclosureSEC source: 0000784199-20-000220 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Balance reflects a 6,666 share correction that should have been added to the last total. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 21:27 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionStockOption(Right to Buy) · Derivative | 16,666 | $9.97 Strike: $9.97 | $166,160.02 |
DisclosureSEC source: 0000784199-20-000214 · certent-form4.xml · derivative · entry 3 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,666 shares Expires 2021-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/26/2015 Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 21:27 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
SaleCommon Stock | 16,666 | $23.00 | $383,318.00 |
DisclosureSEC source: 0000784199-20-000214 · certent-form4.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,567 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 1, 2020. F2 · price: Reflects the price of $23.00 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 21:27 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionCommon Stock | 16,666 | $9.97 | $166,160.02 |
DisclosureSEC source: 0000784199-20-000214 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on June 1, 2020. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 21:59 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,666 | $9.97 Strike: $9.97 | $66,460.02 |
DisclosureSEC source: 0000784199-20-000210 · certent-form4.xml · derivative · entry 3 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,666 shares Expires 2021-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/26/2015 Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 21:59 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 6,666 | $20.78 | $138,502.82 |
DisclosureSEC source: 0000784199-20-000210 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,976 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 6, 2020. F2 · price: Reflects weighted average price. Range was between $20.55 - $21.16. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| December 01, 2020 Filed Dec 2, 2020 21:59 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 6,666 | $9.97 | $66,460.02 |
DisclosureSEC source: 0000784199-20-000210 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 6, 2020. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 21:31 UTC |
Barthold Franz PeterVP, Research & Development
|
Tax withholdingCommon Stock | 654 | $20.93 | $13,688.22 |
DisclosureSEC source: 0000784199-20-000212 · certent-form4.xml · nonDerivative · entry 1 Barthold Franz Peter · CIK 0001806854 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,280 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 22:06 UTC |
Maier Dennis BVice President, Operations
|
Tax withholdingCommon Stock | 1,585 | $17.62 | $27,927.70 |
DisclosureSEC source: 0000784199-20-000204 · certent-form4.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,083 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| September 16, 2020 Filed Sep 16, 2020 17:23 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 7,500 | $16.74 | $125,523.75 |
DisclosureSEC source: 0000784199-20-000190 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,274 Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 21:53 UTC |
Davis John ESenior VP, Global Sales
|
PurchaseCommon Stock | 10,000 | $16.65 | $166,459.00 |
DisclosureSEC source: 0000784199-20-000194 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,451 F1 · price: Reflects the average weighted price of $16.6459 the shares were purchased. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 21:50 UTC |
Bullock JamesDirector
|
PurchaseCommon Stock | 10,000 | $16.63 | $166,273.00 |
DisclosureSEC source: 0000784199-20-000192 · certent-form4.xml · nonDerivative · entry 1 Bullock James · CIK 0001172340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,023 F1 · price: Reflects the average weighted price of $16.6273 the shares were purchased. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| September 16, 2020 Filed Oct 1, 2020 13:00 UTC Amendment |
Mackin James PPresident & CEO
|
PurchaseCommon Stock | 7,500 | $16.74 | $125,523.75 |
DisclosureSEC source: 0000784199-20-000196 · certent-form4a.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,274 F1 · price: Reflects open market purchase by reporting person. The original form 4 noted the transaction as an acquired grant in error. Read SEC document |
| July 01, 2020 Filed Jan 11, 2021 21:50 UTC |
Maier Dennis BVice President, Operations
|
GrantESPP · Derivative | 170 | $16.18 Strike: $16.18 | $2,749.84 |
DisclosureSEC source: 0000784199-21-000006 · certent-form5.xml · derivative · entry 5 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170 Underlying: Common Stock · 170 shares Expires 2020-12-31 Read SEC document |
| July 01, 2020 Filed Jan 11, 2021 21:50 UTC |
Maier Dennis BVice President, Operations
|
Exercise / conversionCommon Stock | 170 | $16.18 | $2,749.84 |
DisclosureSEC source: 0000784199-21-000006 · certent-form5.xml · nonDerivative · entry 2 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| July 01, 2020 Filed Jan 11, 2021 21:47 UTC |
Holloway Jean FVP, General Counsel
|
GrantESPP · Derivative | 189 | $16.18 Strike: $16.18 | $3,057.17 |
DisclosureSEC source: 0000784199-21-000004 · certent-form5.xml · derivative · entry 5 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189 Underlying: Common Stock · 189 shares Expires 2020-12-31 Read SEC document |
| July 01, 2020 Filed Jan 11, 2021 21:47 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 189 | $16.18 | $3,057.17 |
DisclosureSEC source: 0000784199-21-000004 · certent-form5.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| June 30, 2020 Filed Jan 11, 2021 21:52 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
Exercise / conversionESPP · Derivative | 79 | $16.29 Strike: $16.29 | $1,287.27 |
DisclosureSEC source: 0000784199-21-000008 · certent-form5.xml · derivative · entry 3 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 79 shares Expires 2020-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2020 Filed Jan 11, 2021 21:50 UTC |
Maier Dennis BVice President, Operations
|
Exercise / conversionESPP · Derivative | 171 | $16.29 Strike: $16.29 | $2,786.36 |
DisclosureSEC source: 0000784199-21-000006 · certent-form5.xml · derivative · entry 4 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 171 shares Expires 2020-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2020 Filed Jan 11, 2021 21:47 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionESPP · Derivative | 790 | $16.29 Strike: $16.29 | $12,872.66 |
DisclosureSEC source: 0000784199-21-000004 · certent-form5.xml · derivative · entry 4 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 790 shares Expires 2020-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2020 Filed Jan 11, 2021 21:45 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionESPP · Derivative | 922 | $16.29 Strike: $16.29 | $15,023.53 |
DisclosureSEC source: 0000784199-21-000002 · certent-form5.xml · derivative · entry 3 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 922 shares Expires 2020-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:41 UTC |
BEVEVINO DANIEL JDirector
|
GrantCommon Stock | 5,667 | $22.94 | $130,000.98 |
DisclosureSEC source: 0000784199-20-000155 · certent-form4.xml · nonDerivative · entry 1 BEVEVINO DANIEL J · CIK 0001186458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,437 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:50 UTC |
Salveson Jon WDirector
|
GrantCommon Stock | 5,667 | $22.94 | $130,000.98 |
DisclosureSEC source: 0000784199-20-000167 · certent-form4.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,216 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:49 UTC |
MORGAN HARVEYDirector
|
GrantCommon Stock | 5,667 | $22.94 | $130,000.98 |
DisclosureSEC source: 0000784199-20-000165 · certent-form4.xml · nonDerivative · entry 1 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,070 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:47 UTC |
McCall Ronald DDirector
|
GrantCommon Stock | 5,667 | $22.94 | $130,000.98 |
DisclosureSEC source: 0000784199-20-000163 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,433 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:45 UTC |
Burbank Jeffrey HDirector
|
GrantCommon Stock | 5,667 | $22.94 | $130,000.98 |
DisclosureSEC source: 0000784199-20-000161 · certent-form4.xml · nonDerivative · entry 1 Burbank Jeffrey H · CIK 0001341411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,172 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:44 UTC |
Bullock JamesDirector
|
GrantCommon Stock | 5,667 | $22.94 | $130,000.98 |
DisclosureSEC source: 0000784199-20-000159 · certent-form4.xml · nonDerivative · entry 1 Bullock James · CIK 0001172340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,023 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:42 UTC |
Borgstrom Marna PDirector
|
GrantCommon Stock | 5,667 | $22.94 | $130,000.98 |
DisclosureSEC source: 0000784199-20-000157 · certent-form4.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,464 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 20:38 UTC |
ACKERMAN THOMAS FDirector
|
GrantCommon Stock | 5,667 | $22.94 | $130,000.98 |
DisclosureSEC source: 0000784199-20-000153 · certent-form4.xml · nonDerivative · entry 1 ACKERMAN THOMAS F · CIK 0001141720 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,272 F1 · shares: Represents shares of restricted stock that cliff vest on June 1, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 28, 2020 Filed May 29, 2020 12:06 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 3,000 | $23.81 | $71,415.30 |
DisclosureSEC source: 0000784199-20-000148 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,642 F1 · price: Reflects the price the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price Read SEC document |
| May 22, 2020 Filed May 27, 2020 21:50 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GiftCOMMON STOCK | 125 | $22.86 | $2,857.50 |
DisclosureSEC source: 0000784199-20-000145 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,567 F1 · shares: 125 shares were gifted by the reporting person. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:25 UTC |
Salveson Jon WDirector
|
GrantCommon Stock | 1,399 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000113 · certent-form4.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,549 F1 · shares: RSA Covid grant vests on May 4, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:23 UTC |
MORGAN HARVEYDirector
|
Grantcommon Stock | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000111 · certent-form4.xml · nonDerivative · entry 1 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,403 F1 · shares: RSA Covid grant vests on May 4, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:22 UTC |
McCall Ronald DDirector
|
GrantCommon Stock | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000109 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,485 F1 · shares: RSA Covid grant vests on May 4, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:20 UTC |
Burbank Jeffrey HDirector
|
GrantCommon Stock | 1,178 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000107 · certent-form4.xml · nonDerivative · entry 1 Burbank Jeffrey H · CIK 0001341411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,505 F1 · shares: RSA Covid grant vests on May 4, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:18 UTC |
Bullock JamesDirector
|
GrantCommon Stock | 1,289 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000105 · certent-form4.xml · nonDerivative · entry 1 Bullock James · CIK 0001172340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,356 F1 · shares: RSA Covid grant vests on May 4, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:16 UTC |
Borgstrom Marna PDirector
|
GrantCommon Stock | 1,178 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000103 · certent-form4.xml · nonDerivative · entry 1 Borgstrom Marna P · CIK 0001744267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,797 F1 · shares: RSA Covid grant vests on May 4, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:14 UTC |
BEVEVINO DANIEL JDirector
|
GrantCommon Stock | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000101 · certent-form4.xml · nonDerivative · entry 1 BEVEVINO DANIEL J · CIK 0001186458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,770 F1 · shares: RSA Covid grant vests on May 4, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:12 UTC |
ACKERMAN THOMAS FDirector
|
GrantCommon Stock | 1,455 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000099 · certent-form4.xml · nonDerivative · entry 1 ACKERMAN THOMAS F · CIK 0001141720 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,605 F1 · shares: RSA Covid grant vests on May 4, 2021, provided the status as a Director with CryoLife continues through such date. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:42 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
GrantPhantom Stock · Derivative | 1,871 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000784199-20-000135 · certent-form4.xml · derivative · entry 1 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,387 Underlying: Phantom Stock · 1,871 shares Expires not disclosed F1 · derivative.exercise_price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.exercise_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.expiration_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:41 UTC |
Maier Dennis BVice President, Operations
|
GrantPhantom Stock · Derivative | 1,526 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000784199-20-000133 · certent-form4.xml · derivative · entry 1 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,668 Underlying: Phantom Stock · 1,526 shares Expires not disclosed F1 · derivative.exercise_price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.exercise_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.expiration_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:39 UTC |
Mackin James PPresident & CEO
|
GrantPhantom Stock · Derivative | 3,832 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000784199-20-000131 · certent-form4.xml · derivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,774 Underlying: Phantom Stock · 3,832 shares Expires not disclosed F1 · derivative.exercise_price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.exercise_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.expiration_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:35 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantPhantom Stock · Derivative | 2,421 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000784199-20-000129 · certent-form4.xml · derivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,692 Underlying: Phantom Stock · 2,421 shares Expires not disclosed F1 · derivative.exercise_price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.exercise_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.expiration_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:33 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantPhantom Stock · Derivative | 1,611 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000784199-20-000127 · certent-form4.xml · derivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,642 Underlying: Phantom Stock · 1,611 shares Expires not disclosed F1 · derivative.exercise_price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.exercise_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.expiration_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:31 UTC |
Holloway Jean FVP, General Counsel
|
GrantPhantom Stock · Derivative | 2,011 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000784199-20-000125 · certent-form4.xml · derivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,051 Underlying: Phantom Stock · 2,011 shares Expires not disclosed F1 · derivative.exercise_price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.exercise_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.expiration_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:28 UTC |
Getz Matthew AVP, Human Resources
|
GrantPhantom Stock · Derivative | 1,396 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000784199-20-000123 · certent-form4.xml · derivative · entry 1 Getz Matthew A · CIK 0001784253 · VP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,176 Underlying: Phantom Stock · 1,396 shares Expires not disclosed F1 · derivative.exercise_price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.exercise_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.expiration_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:26 UTC |
Davis John ESenior VP, Global Sales
|
GrantPhantom Stock · Derivative | 1,941 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000784199-20-000121 · certent-form4.xml · derivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,451 Underlying: Phantom Stock · 1,941 shares Expires not disclosed F1 · derivative.exercise_price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.exercise_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.expiration_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. Read SEC document |
| May 05, 2020 Filed May 7, 2020 21:22 UTC |
Capps Scott BVP, Clinical Research
|
GrantPhantom Stock · Derivative | 1,797 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000784199-20-000119 · certent-form4.xml · derivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,006 Underlying: Phantom Stock · 1,797 shares Expires not disclosed F1 · derivative.exercise_price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · price: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.exercise_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. F1 · derivative.expiration_date: Represents phantom stock that is the economic equivalent of one share of CRY common stock. This phantom stock will not convert to shares, but will be settled in cash on or about April 27, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.